Interestingly, CD48 (the ligand for the CD244 receptor) was significantly downregulated on B-cells in B-ALL patients compared to controls (68.7 ± 21.7% vs. 95.6 ± 6.3%, p < 0.0001), as shown in Fig. 3. Here, CD48 is linked to acute lymphoblastic leukemia.